)
Edge12 Dec 2025
Running on Clouds: The Story of On
The story of how a Swiss runner's pursuit of a new running sensation became On, aiming to be the most premium global sportswear brand worldwide.
CANbridge Pharmaceuticals (1228) investor relations material
CANbridge Pharmaceuticals H1 2025 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.H1 2025 earnings summary31 Aug, 2025
Executive summary
Achieved key milestones in rare disease drug pipeline, including new product approvals, expanded insurance coverage in China, and strategic cooperation with Baheal Medical, securing RMB50 million engagement fee and HK$100 million equity investment.
Three rare disease products passed China's NHSA innovative drug catalog review, supporting future reimbursement and market access.
Streamlined operations, reduced workforce to 45, and prioritized key rare disease programs amid challenging biotech funding environment.
Commercial launches of Hunterase® and Livmarli® accelerated patient identification and insurance coverage.
Gaurunning® received marketing approval for Gaucher disease in China, marking a significant product milestone.
Financial highlights
Revenue dropped 50.3% year-over-year to RMB22.2 million, mainly due to cessation of Nerlynx® sales in Taiwan; excluding this, revenue declined 6.9%.
Gross profit was RMB15.4 million with a margin of 69.3%, up from 65.7% last year.
Other income and gains surged to RMB104.1 million, driven by a RMB101.0 million gain from US lease termination.
R&D expenses fell 89.6% to RMB18.0 million after Gaurunning NDA approval; admin and selling expenses also decreased significantly.
Reported profit of RMB59.2 million (vs. RMB247.3 million loss prior year), mainly from non-recurring items; adjusted loss narrowed to RMB37.4 million.
Cash and bank balances at RMB2.0 million, with net current liabilities of RMB462.7 million and net liabilities of RMB409.1 million as of June 30, 2025.
Outlook and guidance
Optimistic for H2 2025, focusing on pipeline streamlining, capital efficiency, and leveraging Baheal Medical partnership for growth.
Plans to accelerate commercialization of Gaurunning and improve profitability of Hunterase® and Livmarli®.
How does Baheal deal impact going concern risk?
What drives 2H25 rare disease revenue growth?
What is the updated pipeline strategy?
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Next CANbridge Pharmaceuticals earnings date
H2 202530 Mar, 2026
Next CANbridge Pharmaceuticals earnings date
H2 202530 Mar, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
CANbridge Pharmaceuticals Inc is a Chinese biopharmaceutical company focused on developing and commercializing treatments for rare diseases and cancer. The company engages in drug discovery, licensing, and clinical development, with a pipeline spanning gene therapy and biologics. It operates in both China and global markets through partnerships and R&D collaborations. The company is headquartered in Beijing, China, and its shares are listed on the HKEX.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage